Process intensification has reduced the cost of mAb manufacturing, but tweaks across bioproduction will be needed to reduce ...

Many recombinant viral vectors for expression of ectopic antigens mimic a natural infection and can induce a robust immune response against certain pathogens and tumors. Host-restricted poxviruses and ...

For at least the last decade, protein purification has increasingly been viewed as a process bottleneck—not just for individual unit operations, but for the entire purification train. Current wisdom ...

Purifying novel therapeutics remains a major challenge as increasingly complex molecules move towards the clinic. With Lonza, you can ensure optimal product quality and bring your molecules to the ...

The Downstream Processing Market is entering a high-stakes expansion phase driven by surging biopharmaceutical production, intensified demand for monoclonal antibodies, and rapid scale-up of cell and ...

Biopharmaceutical downstream processing requires precise control of multiple unit operations—from chromatography and filtration to viral inactivation—to ensure product quality and therapeutic efficacy ...

Over the last few years, the number of recombinant pharmaceutical products that have entered the regulatory fray to gain approval for marketing has grown rapidly, and is now in the hundreds. As ...

In this brochure, Thermo Scientific takes a closer look at how integrated hot-melt extrusion (HME) workflows, paired with flexible downstream processing technologies from Thermo Fisher Scientific, can ...

LEWES, Del., April 15, 2026 /PRNewswire/ -- The Global Downstream Processing Market is projected to grow at a CAGR of 6.8% from 2026 to 2033, according to a new report published by Verified Market ...